Hannover Medical School (MHH) are now using a new treatment procedure for severe heart attacks. The team led by Professor Dr. Andreas Schäfer, Head of Cardiovascular Intensive Care Medicine, is using - for
to accept professional help. This is where the low-threshold therapy offered by Dr. Glahn and his team of psychiatric and psychological specialists comes in. It is intended for people at all stages of
researchers, they must first be standardised and structured. This is being done at the MHH by the team led by Dr. Matthias Gietzelt, research associate at the PLRI. "We have already prepared the infrastructure
specific cellular immunity should be transferred to the patients. In a multicentre case series, a team from Hannover Medical School (MHH) led by Professor Dr. Britta Eiz-Vesper from the I nstitute of
the Director of the MHH Clinic for Paediatric Haematology and Oncology. The international research team conducted a meta-analysis based on 11 studies that included results on germline testing of a total
until now. Therefore, there are still no drugs that can specifically promote healing. Now a research team led by Professor Dr. Kai Wollert, Head of Molecular and Translational Cardiology at the Department
form antibodies against the gene shuttle and thus prevent the desired treatment success. The research team led by Dr. Simon Krooss therefore wants to develop a new means of transport that does not trigger
is based on high-energy X-rays generated by synchrotron particle accelerators. The international team of this worldwide unique project entitled "Human Organ Project" is composed of physicians from the
deaf before insertion of a hearing prosthesis such as a cochlear implant (CI). Now, a German-American team of authors led by Professor Dr. Andrej Kral, Scientific Director of the Institute for Audio and N
the therapy goals more effectively,” explains PhD student and project coordinator Saskia Hamers. The team headed by Professor Krüger wants to find out whether self-chosen measures can improve the well-being